MétaCan
Menu
Back to cohort
Record W4399684427 · doi:10.2337/db24-911-p

911-P: Effect of Dapagliflozin on Blood and Breath Ketones during Supervised Insulin Withdrawal in Adults with Type 1 Diabetes

2024· article· en· W4399684427 on OpenAlexaboutno aff
MAX C. PETERSEN, Kai Jones, Kathryn L. Bohnert, Alexander M. Markov, Maamoun Salam, Petra Krutilova, ALEXIS M. MCKEE, Samantha E. Adamson, Janet B. McGill

Bibliographic record

VenueDiabetes · 2024
Typearticle
Languageen
FieldMedicine
TopicDiabetes Treatment and Management
Canadian institutionsnot available
Fundersnot available
KeywordsDapagliflozinMedicineType 2 diabetesInternal medicineInsulinEndocrinologyDiabetes mellitusHypoglycemiaCrossover studyPlacebo

Abstract

fetched live from OpenAlex

Introduction: SGLT2 inhibitors increase DKA risk, limiting their use in T1D. To understand the effect of SGLT2i on ketone production, we measured glucose, beta-hydroxybutyrate (BOHB) and breath acetone (BrACE) with and without dapagliflozin during supervised insulin withdrawal in adults with T1D. Methods: 20 adults with T1D underwent on-site supervised insulin withdrawal twice in a randomized crossover design: during usual care and after treatment with dapagliflozin (10 mg daily for 2 weeks plus the test day). After insulin withdrawal, capillary blood glucose, BOHB, and BrACE measurements were obtained at least hourly until stopping rules were met (glucose >400 mg/dL, BOHB >3 mmol/L, >8 hours elapsed, or participant request). Results: Mean (± SD) age was 48 ± 18 years, with baseline HbA1c 7.0 ± 0.9%. The maximal BOHB and BrACE values achieved during supervised insulin withdrawal were both greater with dapagliflozin than usual care (BOHB: 2.4 ± 1.2 vs. 1.6 ± 1.0 mmol/L, P <0.001; BrACE: 13.7 ± 7.5 vs. 8.7 ± 5.7, P = 0.004). Adjusted for time from insulin withdrawal, dapagliflozin treatment was associated with significantly greater BOHB and BrACE concentration (both P <0.001 by ANCOVA). The proportions of participants reaching BOHB >1.5 mmol/L and >2.5 mmol/L during supervised insulin withdrawal were greater in the dapagliflozin arm (74% vs. 37% with BOHB >1.5 mmol/L; 53% vs. 16% with BOHB >2.5 mmol/L; both P <0.05 by McNemar’s test). Blood glucose reached a lower maximum (218 ± 53 vs. 302 ± 58 mg/dL, P <0.001) in the dapagliflozin arm and did not significantly change during insulin withdrawal in the dapagliflozin arm (P for linear trend = 0.91). Conclusion: In adults with T1D undergoing up to 8 hours of supervised insulin withdrawal after dapagliflozin treatment, blood and breath ketone concentrations were significantly greater compared to usual care and in the absence of significant hyperglycemia. Disclosure M.C. Petersen: None. K.E. Jones: None. K.L. Bohnert: None. A.M. Markov: None. M. Salam: None. P. Krutilova: None. A.M. McKee: Advisory Panel; Medtronic, Novo Nordisk. Employee; Novo Nordisk. S.E. Adamson: None. J.B. McGill: Advisory Panel; Bayer Inc., Boehringer-Ingelheim, ClearNote Health, Lilly Diabetes, MannKind Corporation, Novo Nordisk. Research Support; Novo Nordisk. Funding JDRF (2-SRA-2022-1190-M-B)

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.206
Teacher spread0.203 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueDiabetesSame topicDiabetes Treatment and ManagementFrench-language works237,207